A

Amgen

Makes biotech medicines for serious illnesses

Contracts & Pricing Strategy - Associate Director

Corporate Finance & FP&AConfirmed live in the last 24 hours
Full-timeRemote in USARemote

About the Job

Requirements

  • A doctorate degree and 3 years of pricing, contracting, market access, finance, accounting, analytics, or sales and marketing operations experience; or a master's degree and 5 years of that experience; or a bachelor's degree and 7 years; or an associate's degree and 12 years; or a high school diploma or GED and 14 years.
  • Substantial U.S. pharmaceutical pricing, payer or pharmacy benefit manager contracting, gross-to-net forecasting, or launch financial-planning experience, ideally in a high-volume chronic or cardiometabolic market.
  • Demonstrated ownership of an enterprise forecast or economic model integrating assumptions from multiple business owners and supporting senior decisions.
  • Experience with reimbursed, cash, employer, affordability, trade, and government flows and their implications for gross-to-net and price reporting.
  • Ability to govern eligible-life and membership cohorts, channel migration, transaction economics, data lineage, and model controls.
  • Strong executive communication and ability to influence without direct authority.
  • Advanced Excel and enterprise planning or deal-modeling experience.

Responsibilities

  • Lead development of U.S. pricing and contracting recommendations for MariTide across commercial, Medicare, and Medicaid channels, payers, and pharmacy benefit managers.
  • Build account and portfolio economics, bid and negotiation scenarios, access-price trade-offs, and guardrails.
  • Partner with Coverage, Market Access, Contract Development, and Contracting and Pricing Execution to translate approved strategy into executable contract terms.
  • Lead the Obesity latest estimate discount rate process and maintain the integrated gross-to-net and net-sales view used in launch planning, quarterly business reviews, and long-range planning.
  • Reconcile rebates, fees, affordability, trade, government, and channel-mix assumptions; run base, upside, and downside scenarios; document key dependencies; and explain actual-to-plan variances and changes in forward assumptions.
  • Partner with the Consumer Director and Employer Lead Director to incorporate approved retail-pharmacy, cash-reimbursement, and Direct to Employer assumptions into gross-to-net.
  • Model patient contribution, pharmacy and fulfillment fees, employer and member contributions, program fees, eligible lives, sites, enrollment, activation, utilization, persistence, and ramp.
  • Govern membership inputs and reconcile patient migration and population overlap across channels.
  • Translate global value and pricing considerations into U.S. launch scenarios and communicate U.S. channel implications to global partners.
  • Develop assumptions, analogs, sensitivity ranges, and decision triggers where actuals do not exist.
  • Extend the pricing and gross-to-net architecture to future indications and sequencing decisions as populations, evidence, benefit management, utilization, and channel mix evolve.
  • Lead cross-functional pricing workstreams with Finance, Forecasting, Accounting, Government Pricing, Legal, Compliance, Privacy, Trade, Brand, and Market Access.
  • Establish common model definitions, documentation, and review cadence; identify duplicate-discount, classification, reporting, privacy, and channel-conflict risks; and present recommendations, alternatives, and unresolved issues to the Director and senior governance.

About the Company

Amgen

Makes biotech medicines for serious illnesses

Amgen develops and makes biologic medicines, which are drugs built from proteins and antibodies grown in living cells, for serious conditions such as heart disease, cancer, and bone loss. Its anemia drug Epogen, approved in 1989, became one of the biotechnology industry's first blockbuster medicines. Amgen grows these drugs in large tanks called bioreactors, and its products include the cholesterol drug Repatha, the bone-building drug Evenity, and the severe asthma drug Tezspire. It earns money by selling these medicines, mostly through large drug wholesalers that supply hospitals and pharmacies. Amgen was founded in 1980 and is based in Thousand Oaks, California.

Company size
10,001+
Company stage
IPO
Headquarters
Thousand Oaks, CA
Founded
1980

Recently Posted Jobs

Explore more opportunities at Amgen

See more jobs